mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |